Goldman Sachs Group Inc Ani Pharmaceuticals Inc Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 699,618 shares of ANIP stock, worth $41.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
699,618
Previous 716,069 2.3%
Holding current value
$41.1 Million
Previous $42.7 Million 9.47%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$53.35 - $61.74 $877,660 - $1.02 Million
-16,451 Reduced 2.3%
699,618 $38.7 Million
Q3 2024

Nov 14, 2024
BUY
$54.33 - $65.72 $34 Million - $41.1 Million
626,110 Added 695.99%
716,069 $42.7 Million
Q2 2024

Aug 13, 2024
BUY
$58.53 - $68.82 $1.41 Million - $1.66 Million
24,169 Added 36.74%
89,959 $5.73 Million
Q1 2024

May 15, 2024
BUY
$54.2 - $69.69 $1.33 Million - $1.71 Million
24,589 Added 59.68%
65,790 $4.55 Million
Q4 2023

Feb 13, 2024
BUY
$48.72 - $65.43 $97,781 - $131,318
2,007 Added 5.12%
41,201 $2.27 Million
Q3 2023

May 14, 2024
SELL
$50.28 - $64.61 $100,911 - $129,672
-2,007 Reduced 4.87%
39,194 $2.28 Million
Q3 2023

Nov 14, 2023
SELL
$50.28 - $64.61 $1.71 Million - $2.2 Million
-34,021 Reduced 46.47%
39,194 $2.28 Million
Q2 2023

May 14, 2024
BUY
$37.29 - $53.83 $226,201 - $326,532
6,066 Added 9.03%
73,215 $3.94 Million
Q2 2023

Aug 14, 2023
BUY
$37.29 - $53.83 $226,201 - $326,532
6,066 Added 9.03%
73,215 $3.94 Million
Q1 2023

May 14, 2024
SELL
$37.61 - $45.72 $196,963 - $239,435
-5,237 Reduced 7.23%
67,149 $2.67 Million
Q1 2023

May 11, 2023
SELL
$37.61 - $45.72 $196,963 - $239,435
-5,237 Reduced 7.23%
67,149 $2.67 Million
Q4 2022

May 14, 2024
SELL
$31.9 - $41.95 $645,656 - $849,068
-20,240 Reduced 21.85%
72,386 $2.91 Million
Q4 2022

Feb 13, 2023
SELL
$31.9 - $41.95 $645,656 - $849,068
-20,240 Reduced 21.85%
72,386 $2.91 Million
Q3 2022

May 14, 2024
SELL
$29.83 - $38.01 $1.29 Million - $1.64 Million
-43,183 Reduced 31.8%
92,626 $2.98 Million
Q3 2022

Nov 10, 2022
SELL
$29.83 - $38.01 $1.29 Million - $1.64 Million
-43,183 Reduced 31.8%
92,626 $2.98 Million
Q2 2022

May 14, 2024
BUY
$23.09 - $33.46 $2.18 Million - $3.17 Million
94,608 Added 229.63%
135,809 $4.03 Million
Q2 2022

Aug 15, 2022
BUY
$23.09 - $33.46 $2.77 Million - $4.02 Million
120,178 Added 768.84%
135,809 $4.03 Million
Q1 2022

May 16, 2022
SELL
$26.91 - $47.15 $607,197 - $1.06 Million
-22,564 Reduced 59.08%
15,631 $439,000
Q4 2021

Feb 14, 2022
SELL
$32.97 - $56.85 $9 Million - $15.5 Million
-273,067 Reduced 87.73%
38,195 $1.76 Million
Q3 2021

Nov 10, 2021
BUY
$26.48 - $35.99 $8.24 Million - $11.2 Million
311,262 New
311,262 $10.2 Million

Others Institutions Holding ANIP

# of Institutions
210
Shares Held
19.2M
Call Options Held
3.4K
Put Options Held
10.8K
View Full List

About ANI PHARMACEUTICALS INC

ANIP Quotes by TradingView
  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.02B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email